Rezira FDA Approval History
FDA Approved: Yes (First approved June 8, 2011)
Brand name: Rezira
Generic name: hydrocodone and pseudoephedrine
Dosage form: Oral Solution
Company: Cypress Pharmaceutical, Inc.
Treatment for: Cough and Nasal Congestion
Rezira (hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive and nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold.
Development Timeline for Rezira
|Jun 23, 2011||FDA Approves Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.